Editorial for “19Fluorine‐MRI Based Longitudinal Immuno‐Microenvironment‐Monitoring for Pancreatic Cancer”

Journal of Magnetic Resonance ImagingEarly View Editorial Editorial for "19Fluorine-MRI Based Longitudinal Immuno-Microenvironment-Monitoring for Pancreatic Cancer" Emily Hoffmann, Emily Hoffmann orcid.org/0000-0002-0958-6699 Clinic of Radiology, University of Münster, Münster, GermanySearch for more papers by this authorCornelius Faber PhD, Corresponding Author Cornelius Faber PhD [email protected] orcid.org/0000-0001-7683-7710 Clinic of Radiology, University of Münster, Münster, GermanySearch for more papers by this author Emily Hoffmann, Emily Hoffmann orcid.org/0000-0002-0958-6699 Clinic of Radiology, University of Münster, Münster, GermanySearch for more papers by this authorCornelius Faber PhD, Corresponding Author Cornelius Faber PhD [email protected] orcid.org/0000-0001-7683-7710 Clinic of Radiology, University of Münster, Münster, GermanySearch for more papers by this author First published: 03 September 2024 https://doi.org/10.1002/jmri.29593 Evidence Level: 5 Technical Efficacy: Stage 2 Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat No abstract is available for this article. References 1Gerwing M, Herrmann K, Helfen A, et al. The beginning of the end for conventional RECIST—Novel therapies require novel imaging approaches. Nat Rev Clin Oncol 2019; 16: 442-458. 10.1038/s41571-019-0169-5 CASPubMedWeb of Science®Google Scholar 2de Visser KE, Joyce JA. The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth. Cancer Cell 2023; 41: 374-403. 10.1016/j.ccell.2023.02.016 PubMedWeb of Science®Google Scholar 3Hoffmann E, Masthoff M, Kunz WG, et al. Multiparametric MRI for characterization of the tumour microenvironment. Nat Rev Clin Oncol 2024; 21: 428-448. 10.1038/s41571-024-00891-1 PubMedGoogle Scholar 4Maxouri O, Bodalal Z, Daal M, et al. How to 19F MRI: Applications, technique, and getting started. BJR Open 2023; 5:20230019. PubMedGoogle Scholar 5Reichardt W, Gewalt T, Hafner P, et al. 19Fluorine-MRI based longitudinal immuno-microenvironment-monitoring for pancreatic cancer. J Magn Reson Imaging 2024. https://doi.org/10.1002/jmri.29589. 10.1002/jmri.29589 PubMedGoogle Scholar 6Faber C, Schmid F. Pulse sequence considerations and schemes. Fluorine magnetic resonance imaging, Vol 1. Singapore: Pan Stanford Publishing; 2017. p 3-27. Google Scholar 7Chapelin F, Gao S, Okada H, Weber TG, Messer K, Ahrens ET. Fluorine-19 nuclear magnetic resonance of chimeric antigen receptor T cell biodistribution in murine cancer model. Sci Rep 2017; 7:17748. 10.1038/s41598-017-17669-4 PubMedWeb of Science®Google Scholar 8Bouchlaka MN, Ludwig KD, Gordon JW, et al. (19)F-MRI for monitoring human NK cells in vivo. Onco Targets Ther 2016; 5:e1143996. Google Scholar 9Ahrens ET, Helfer BM, O'Hanlon CF, Schirda C. Clinical cell therapy imaging using a perfluorocarbon tracer and fluorine-19 MRI. Magn Reson Med 2014; 72: 1696-1701. 10.1002/mrm.25454 CASPubMedWeb of Science®Google Scholar 10Kabacaoglu D, Ciecielski KJ, Ruess DA, Algül H. Immune checkpoint inhibition for pancreatic ductal adenocarcinoma: Current limitations and future options. Front Immunol 2018; 9: 9. 10.3389/fimmu.2018.01878 PubMedGoogle Scholar Early ViewOnline Version of Record before inclusion in an issue ReferencesRelatedInformation